brainQr Therapeutics develops first-in-class oral small-molecule protein stabilizers for disease-modifying treatments of Alzheimer’s and other neurodegenerative diseases.
Printed courtesy of www.gaccny.com/en/ – Contact the German American Chamber of Commerce, Inc. for more information.
120 Wall Street, 20th Floor, New York, NY 10005 – +1 (212) 974-8855 – membership@gaccny.com